Published in AIDS Weekly, November 24th, 2003
According to recent research published in the journal Comparative Immunology Microbiology and Infectious Diseases, "Vaccine approaches against AIDS have focused on inducing cellular immune responses, since many studies revealed the role of T cell responses in the control of human immunodeficiency virus or simian immunodeficiency virus (SIV) infections."
"The experimental infection of rhesus macaques with SIV or chimeric SHIV is routinely used as a model for AIDS," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.